1-hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro
- 1 October 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (10) , 1511-1515
- https://doi.org/10.1016/0277-5379(87)90094-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Comparison between Succinate Dehydrogenase Inhibition Test and Subrenal Capsule Assay for Chemosensitivity TestingOncology, 1987
- Partial hepatectomy alters sensitivity of rat hepatocytes to 5-fluorouracilCancer Letters, 1986
- Cooperative evaluation of human tumor chemosensitivity in the soft-agar assay and its clinical correlationsZeitschrift für Krebsforschung und Klinische Onkologie, 1985
- Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyCancer, 1983
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Absorption and Excretion of a New Oral Antitumor Drug, 1-Hexylcarbamoyl-5-Fluorouracil (HCFU), in Cancer PatientsJapanese Journal of Clinical Oncology, 1980
- Antitumor activity of metabolites of 1-hexylcarbamoyl-5-fluorouracil and related compounds against L1210 leukemia in vivo and L5178Y lymphoma cells in vitro.Journal of Pharmacobio-Dynamics, 1980
- Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in Lewis lung carcinoma and B16 melanoma.Journal of Pharmacobio-Dynamics, 1978
- Metabolic Fate of 1-Hexylcarbamoyl-5-fluorouracil in RatsXenobiotica, 1978